scispace - formally typeset
J

Joan S. Brugge

Researcher at Harvard University

Publications -  302
Citations -  51153

Joan S. Brugge is an academic researcher from Harvard University. The author has contributed to research in topics: Proto-oncogene tyrosine-protein kinase Src & Phosphorylation. The author has an hindex of 115, co-authored 286 publications receiving 47965 citations. Previous affiliations of Joan S. Brugge include Howard Hughes Medical Institute & Massachusetts Institute of Technology.

Papers
More filters
Journal ArticleDOI

A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth.

TL;DR: It is found that Bcl-xL overexpression in mouse mammary epithelial cells does not induce primary tumor formation or enhance MEK-induced tumorigenesis within the mammary gland environment, however, it strongly enhances metastatic potential.
Journal ArticleDOI

Fibroblast Growth Factor Receptor 1–Transformed Mammary Epithelial Cells Are Dependent on RSK Activity for Growth and Survival

TL;DR: The transforming activity of FGFR1 in mammary epithelial cells is shown and RSK is identified as a critical component ofFGFR1 signaling in lobular carcinomas, thus implicating RSK as a candidate therapeutic target in FG FR1-expressing tumors.
Journal ArticleDOI

Clustering of Syk is sufficient to induce tyrosine phosphorylation and release of allergic mediators from rat basophilic leukemia cells.

TL;DR: Clustering of the Syk chimera was found to be sufficient to stimulate early and late events normally induced by clustering of Fc epsilon RI, which strongly suggest that Syk is an early and critical mediator of multiple signaling pathways that emanate from the Fc EpsilonRI receptor and give rise to the allergic response.
Journal ArticleDOI

Rous sarcoma virus-induced phosphorylation of a 50,000-molecular weight cellular protein

TL;DR: It is demonstrated that a phosphoserine-containing form ofpp50 is present in uninfected chicken cells and that on transformation by RSV, a second form of pp50, detectable by two-dimensional analysis of 32P-labelled proteins, contains phosphotyrosine as well as phosphoserines.
Journal ArticleDOI

Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids

TL;DR: In this paper, an optimized, highly versatile protocol for long-term culture of organoids derived from either normal human breast tissues or breast cancer (BC) tissues, as well as culturing conditions for a panel of 45 biobanked samples, including BC organoids covering all major disease subtypes (triple negative, estrogen receptor-positive/progesterone receptor)-positive and human epidermal growth receptor 2-positive).